VA
LLY icon

Vident Advisory’s Eli Lilly LLY Stock Holding History

Vident Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.1M Buy
70,087
+2,518
+4% +$2.57M 0.61% 31
2026
Q1 		$62.1M Buy
67,569
+8,339
+14% +$8.45M 0.53% 32
2025
Q4 		$63.7M Buy
59,230
+2,874
+5% +$2.75M 0.58% 34
2025
Q3 		$43M Buy
56,356
+6,318
+13% +$4.7M 0.41% 51
2025
Q2 		$39M Buy
50,038
+3,937
+9% +$3.06M 0.44% 50
2025
Q1 		$38.1M Buy
46,101
+13,484
+41% +$11.2M 0.56% 33
2024
Q4 		$25.2M Buy
32,617
+4,500
+16% +$3.73M 0.44% 45
2024
Q3 		$24.9M Buy
28,117
+8,586
+44% +$7.72M 0.63% 28
2024
Q2 		$17.7M Buy
19,531
+880
+5% +$704K 0.49% 38
2024
Q1 		$14.5M Buy
18,651
+1,688
+10% +$1.2M 0.3% 112
2023
Q4 		$9.89M Sell
16,963
-3,668
-18% -$2.14M 0.25% 135
2023
Q3 		$11.1M Buy
+20,631
New +$10.6M 0.34% 73

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vident Advisory's LLY Position: Q2 2026 in Review

Vident Advisory increased its Eli Lilly (LLY) stake by 3.7% in Q2 2026, buying an estimated $2.57M and bringing the position to 70,087 shares worth $84.1M. The position accounts for 0.61% of the portfolio, ranked #31.

Vident Advisory first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vident Advisory held 70,087 shares of Eli Lilly worth $84.1M as of Q2 2026.
  • Vident Advisory bought 2,518 Eli Lilly shares in Q2 2026, an estimated $2.57M.
  • Eli Lilly made up 0.61% of Vident Advisory's portfolio in Q2 2026, its #31 holding.
  • Vident Advisory first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.